167 related articles for article (PubMed ID: 15834934)
1. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
[No Abstract] [Full Text] [Related]
2. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
4. [Postoperative arterial infusion chemotherapy for hepatocellular carcinoma].
Itamoto T; Asahara T; Okamoto Y; Nakahara H; Katayama K; Nomura S; Marubayashi S; Yahata H; Fukuda Y; Dohi K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1493-6. PubMed ID: 1326915
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma.
Boucher E; Corbinais S; Rolland Y; Bourguet P; Guyader D; Boudjema K; Meunier B; Raoul JL
Hepatology; 2003 Nov; 38(5):1237-41. PubMed ID: 14578862
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
Izumi R; Shimizu K; Kiriyama M; Ii T; Iwasa K; Iyobe T; Masutani H; Yagi M; Miyazaki I; Matsui O
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1497-500. PubMed ID: 1326916
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H
Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Does interferon-alpha prevent recurrence of malignant tumors in patients with hepatitis C - related liver cancer?
Ann Intern Med; 2001 May; 134(10):S-7. PubMed ID: 11357861
[No Abstract] [Full Text] [Related]
11. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic chemolipiodolization for postoperative hepatoma patients.
Shimoda M; Bando T; Nagata T; Shirosaki I; Sakamoto T; Tsukada K
Hepatogastroenterology; 2001; 48(38):493-7. PubMed ID: 11379340
[TBL] [Abstract][Full Text] [Related]
13. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
[TBL] [Abstract][Full Text] [Related]
14. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Takenaka K; Yoshida K; Nishizaki T; Korenaga D; Hiroshige K; Ikeda T; Sugimachi K
Am J Surg; 1995 Apr; 169(4):400-4; discussion 405. PubMed ID: 7694977
[TBL] [Abstract][Full Text] [Related]
15. Prevention of intrahepatic hepatocarcinoma recurrence in patients with viral cirrhosis: two potential options.
Tabone M; Pellicano R
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):47-52. PubMed ID: 16554706
[TBL] [Abstract][Full Text] [Related]
16. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Kumar A; Srivastava DN; Bal C
J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146
[TBL] [Abstract][Full Text] [Related]
17. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
18. Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?
Kanmematsu T
Hepatogastroenterology; 1996; 43(12):1404. PubMed ID: 8975938
[No Abstract] [Full Text] [Related]
19. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol.
Lau WY; Lai EC
ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721
[No Abstract] [Full Text] [Related]
20. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
